Grown up congenital heart (GUCH) disease: A half century of change

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 8, Issue 2, 2008, Pages 169-171

  Freeman, Leisa J ^a,b  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AORTA COARCTATION; ASCENDING AORTA; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOLOGY; CARDIOVASCULAR SURGERY; CHROMOSOME DELETION; CONGENITAL HEART DISEASE; CORONARY ARTERY OBSTRUCTION; DEFIBRILLATOR; DEVICE THERAPY; FALLOT TETRALOGY; GREAT VESSELS TRANSPOSITION; HEART ARRHYTHMIA; HEART DEATH; HEART FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; PATIENT CARE; PEDIATRICS; PULMONARY VALVE INSUFFICIENCY; PULMONARY VALVE REPLACEMENT; SHORT SURVEY; SURVIVAL RATE; SURVIVAL TIME; TACHYCARDIA; VASCULAR RING;

EID: 42549153971     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.8-2-169     Document Type: Short Survey

References (12)

1. Department of Health. Adult congenital heart disease. A commissioning guide for services for young people and grown ups with congenital heart disease (GUCH). London: DH, 2006.
2. Report of the British Cardiac Society Working Party. Grown-up congenital heart (GUCH) disease: current needs and provision of services for adolescents and adults with congenital heart diseases in the UK. Heart 2002;88:1-14.
3. De Bono J, Freeman LJ. Long term follow up patients with repair of coarctation of aorta. Heart 2005;91:537-8.
4. Celemeyer DS, Greaves K. Survivors of coarctation repair: fixed but not cured. Heart 2002;88:113-4.
5. Khambadkone S, Coats L, Taylor A et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation 2005;112:1189-97.
6. Rekhraj S, Freeman LJ. Outcome of atrial repair procedures in patients with transposition of the great arteries followed up in a district general hospital. Br J Cardiol 2007;14:19-22 .
7. Freeman LJ. Cardiac Resynchronisation therapy in ccTGA. Device Therapy in Heart Failure. 2007;1:99-100.
8. Leong FT, Freeman LJ, Keavney BD. Genetic influences in adult congenital heart disease. Heart 2007 (commissioned, in press).
9. Botto LD, May K, Fernhoff PM et al. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 2003;112:101-7.
10. Bassett AS, Chow EW, Husted J et al. Clinical features of 78 adults with 22q11 Deletion Syndrome. Am J Med Genet A 2005;138:307-13.
11. Schott J-J, Benson DW, Basson CT et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 1998;281:108-11.
12. Sarkozy A, Conti E, Neri C et al. Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors. J Med Genet 2005;42:e16.